ACTIVE MIND II
Natural health product licensed in Canada
- Other names
- ACTIVE MIND 2.0, Active Mind + P.E.A, P.E.A + Active Mind, P.E.A + Cognition Support, Pro-Active Mind
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80089043
- Status
- Active licence
- Licence date
- 6 November 2018
- Revision date
- 14 June 2021
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide gamma-aminopropanesulfonique Source : Tramiprosate | 33.33 mg | Not calculated |
| N-(2-Hydroxyéthyl)hexadécanamide Source : Palmitoyléthanolamide | 400 mg | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - rhizome | 102 mg | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome Extract : Matériel brut sec Extraction ratio : 12-14:1 Dry plant equivalent : 438.62 mg | 31.33 mg | Not calculated |
Non-medicinal ingredients
Base colorante de l'huile de tournesol(Huile de tournesol, maltodextrine, caséinate de sodium, mono & diglycérides, phosphate dipotassique, lécithine de soja, silicoaluminate de sodium et tocophérols), Gélatine, NA, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Contains ingredients that provides antioxidants for the maintenance of good health and can be used in herbal medicine to help relieve joint inflammation. Homotaurine has been investigated in pre-clinical and early clinical studies. Those studies suggest that homotaurine may help support the specific area of the brain known as the hippocampus, which is primarily involved in memory and learning. This effect has not been studied in a healthy population. Studies show that PEA helps to relieve chronic pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are diagnosed with stomach ulcer or low blood pressure. Do not use if you are pregnant, planning on becoming pregnant, or breastfeeding. Consumption with alcohol, other medications and/or natural health products with sedative properties is not recommended. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
- Effets indésirables connus
Some people may experience nausea, weight loss, dizziness or fainting.
- Précautions et mises en garde
If you experience any weight loss, drowsiness, dizziness, fainting, persistent nausea, vomiting or diarrhea, consult a health care practitioner. Consult a healthcare practitioner prior to use if you are taking antiplatelet medication or blood thinners. Consult a healthcare practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a healthcare practitioner if you have excess stomach acid. Do not exceed recommended daily dose as you may experience more of these symptoms. Consult a health care practitioner if you have any questions. Discontinue use if you experience any confusion, or any unexpected memory loss. Consult a health care practitioner prior to use if you have diabetes. Consult a healthcare practitioner / health care provider / health care professional / doctor / physician if symptoms persist or worsen.
Source
Official Health Canada record, licence 80089043
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.